Lung cancer is the third most common cancer in the UK, with around 46,700 new lung cancer cases diagnosed in the UK every year. Survival rates in the UK are distressingly low and worse than in much of Europe – about 10 per cent of patients survive their disease for five years or more after their diagnosis. Lung cancer has one of the lowest survival outcomes of all cancers because over two-thirds of patients are diagnosed at a late stage when curative treatment is not possible. When diagnosed at its earliest stage, around 73% of patients with non small cell lung cancer and around 56% of patients with small cell lung cancer will survive their disease for at least one year after diagnosis.
Occupational exposures are linked to around 1 in 8 lung cancers in the UK, a large proportion of these due to asbestos resulting in a cancer of the lining of the lungs called mesothelioma. Our researchers are combining both basic molecular biology and clinical research to advance our understanding and treatment of lung cancer.